# Study to Evaluate the Safety and Immunogenicity of Fluarix™ 2006/2007 in Adults Aged 18 Years or Above

> **NCT00345904** · PHASE3 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 120 (—)

## Conditions studied

- Influenza

## Interventions

- **BIOLOGICAL:** Fluarix

## Key facts

- **NCT ID:** NCT00345904
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-07
- **Primary completion:** —
- **Final completion:** 2006-08
- **Target enrollment:** 120 (—)
- **Last updated:** 2016-09-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00345904

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00345904, "Study to Evaluate the Safety and Immunogenicity of Fluarix™ 2006/2007 in Adults Aged 18 Years or Above". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00345904. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*